Delivery Order SPE2DB20D3111-SPE2DB25FA6JB

Award Date 1/23/25
Potential Completion Date 1/24/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $14,789.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product used in medical treatment. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
The federal contract award SPE2DB20D3103|SPE2DB25FL7K6 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,138.27 firm fixed price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical medical commodity. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.19, is a delivery order for the supply of Ceftriaxone 1 GM-D5W bags. The contract has a period of performance through December 5, 2024 and utilizes a firm fixed-price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,584.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical pharmaceutical product used in medical care. This is a Firm Fixed Price Delivery Order contract with a completion date of June 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,445.31, is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The contract is a Firm Fixed Price Delivery Order with a completion date of January 24, 2025. This award is not associated with a set-aside designation, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,058.95, is a Firm Fixed Price Delivery Order for the supply of CEFTRIAXONE 1 GM-D5W BAGS, a pharmaceutical product. The contract has an ultimate completion date of November 12, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ceftriaxone 2 GM-D5W bags. The firm-fixed-price delivery order, valued at $1,461.92, has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This federal contract award, valued at $1,521.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ceftriaxone 1 GM-D5W bags, a critical pharmaceutical product used to treat various medical conditions. This award is not designated as a set-aside contract. The contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,106.00 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Ceftriaxone 1 GM-D5W bags to the Defense Logistics Agency (DLA). The $1,378.25 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 27, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB25FA6JB
    Delivery Order

This federal contract award, SPE2DB20D3111|SPE2DB25FA6JB, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ceftriaxone 1 gm-D5W bags, a type of antibiotic medication, with a ceiling value of $2,132.78.

The award is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:16 AM